How fat droplets accumulate in the nucleus of cells as we age

By Published On: January 8, 2025
How fat droplets accumulate in the nucleus of cells as we age

New research suggests that excessive buildup of nuclear lipid droplets (nLDs) could lead to nuclear instability and may be linked to metabolic conditions such as fatty liver disease, obesity-related disorders, and premature ageing.

The perspective explores how tiny fat droplets, known as nuclear lipid droplets nLDs, accumulate in the nucleus of cells as we age. Unlike regular lipid droplets, which store energy in the cytoplasm, these nuclear droplets may weaken the nucleus by disrupting critical cellular processes.

The findings highlight the potential role of nLDs in cellular ageing and age-related diseases.

Previous research by the authors using Caenorhabditis elegans (C. elegans), a model organism commonly used to study ageing, revealed the role of ATGL-1, an enzyme that regulates fat storage in the nucleus.

When functioning properly, ATGL-1 helps maintain a healthy lipid balance. However, when it becomes inactive or overwhelmed, fat droplets build up around the nuclear lamina, making it more difficult for the cell to function properly.

“These findings establish excessive nuclear lipid deposition as a key hallmark of ageing, with profound implications for nuclear processes such as chromatin organization, DNA repair, and gene regulation,” said the authors.

They emphasise that lifestyle interventions, such as caloric restriction and better insulin regulation, can significantly reduce harmful nLD buildup, reinforcing the role of healthy metabolism in slowing cellular ageing.

They also call for further studies to understand how nLDs behave in human experimental models, particularly in patients with conditions like metabolic syndrome and progeria. A deeper understanding of these processes could lead to treatments designed to preserve cell health and delay age-related diseases.

In summary, by presenting nuclear lipid droplets as potential therapeutic targets, this research perspective presents a new path for exploring treatments aimed at combating age-related diseases driven by lipid dysregulation.

Longevity clinic unveils advanced AI-powered services
Study explores life expectancy after a dementia diagnosis